Treatment of verruca of hands and feet with 32P application therapy and laser

To study and compare the clinical curative effect of extremity verruca with 32P and laser as well as their application values, 229 patients with extremity verruca were chosen by random from outpatient. Out of them, 83 patients were male and 146 were female, with the average age of 34.6 ± 19.5 (x-bar ± s) years. They were randomly divided into two groups: for the laser treatment group consisting of 127 individuals, the wart bodies were eliminated by CO2 laser under local anaesthetization, if there were a lot of locus, the wart bodies were treated in turn. 102 individuals were treated with 32P application therapy. The liquid containing radionuclide 32P was dropped on filter papers, dried and then fixed on the corresponding focus surface for application therapy, applying 4-8 hours continuously (the absorbed dose at the lesion surface reaching 984-1968 cGy) each time and once a week until the lesion recovered. The clinical reaction and curative effect were observed. The clinical effective rate, cure rate, recurrence rate, side effective rate occurrence rate and complication occurrence rate for the laser treatment group are 100%, 55.9%, 44.1%, 17.3% and 25.2%, respectively while they are 100%, 91.2%, 5.9%, 19.6% and 7.8% respectively for the group of 32P application therapy. It is concluded that the treatment of extremity verruca with 32P application therapy is a simple and effective method with features such as safety, little pain, notable curative effect, lower recurrence rate, less side effect and complication. (authors)